Delivery Order SPE2DB24D1205-SPE2DB25FCZTN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,959.60 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,100.31 to AmerisourceBergen Drug Corp for the supply of Vevye 0.1% eye drop in 2ML units. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,653.69 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2mL) under a firm fixed price contract with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, without set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,047.98 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2mL) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, competitively awarded delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for VEVYE 0.1% eye drop in a 2ml formulation, with a ceiling value of $1,047.98. This competitive delivery order, issued under a firm fixed price arrangement, represents a continuation of pharmaceutical supply support through AmerisourceBergen's broader federal contracting relationship. The award carries no set-aside designation and is set for ultimate completion by August 6, 2025, with...
- This delivery order, valued at $3,143.94, was awarded to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vevye 0.1% eye drops in 2ML units to support federal medical procurement needs. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively through the Defense Logistics Agency (DLA). The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25,...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.95 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution in 2ML units. This firm fixed price delivery order, awarded on August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract utilizes no set-aside provisions and was competitively awarded....
- This delivery order, issued on July 30, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $4,203.19 to supply VEVYE 0.1% Eye Drop (2mL) to the Defense Logistics Agency (DLA). The contract is categorized as a child contract under a larger vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. This award was competitively awarded with no set-aside designation,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,587.78, is for the delivery of a specific pharmaceutical product, VEVYE 0.1% Eye Drop 2ML, with a completion date of April 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZTNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,401.85 to AmerisourceBergen Drug Corp for Vevye 0.1% eye drop solution (2 milliliter units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical federal medical vendor supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide. The company's continued receipt of delivery orders under this comprehensive pharmaceutical support vehicle demonstrates its established capability to meet federal procurement requirements for diverse medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/20/25 |